These results illustrated that CPT treatment inhibits inflammatory response and regulates microglia polarization via activating AKT/Nrf2/HO-1 and inhibiting NF-κB pathways in LPS- injected PD mouse model. Here, HMOX1 is linked to Parkinson disease.